Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.

Source:http://linkedlifedata.com/resource/pubmed/id/20126474

Download in:

View as

General Info

PMID
20126474